Human dignity: a guide to policy making in the biotechnology era?
- 13 December 2005
- journal article
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 7 (1) , 72-76
Abstract
This article explores the ways in which human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning. Increasingly, human dignity is used as a form of general condemnation and as blanket justification for regulatory restraint. However, this use of human dignity marks a significant departure from the traditional, human-rights informed view of human dignity that has dominated bioethics debates for decades. In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies.Keywords
This publication has 21 references indexed in Scilit:
- Human Dignity as a Criterion for Science PolicyPLOS Medicine, 2005
- The New French Resistance: Commodification Rejected?Medical Law International, 2005
- Variations and voids: the regulation of human cloning around the worldBMC Medical Ethics, 2004
- The social and ethical issues of post-genomic human biobanksNature Reviews Genetics, 2004
- Genetic equityNature Reviews Genetics, 2004
- Grounding Human DignityDialog, 2004
- Regulating Human Genetics: New Dilemmas For A New MillenniumMedical Law Review, 2004
- Dignity is a useless conceptBMJ, 2003
- Should there be property rights in genes?Philosophical Transactions of the Royal Society B: Biological Sciences, 1997
- “Our” Bodies: Property Rights in Human TissueCanadian Journal of Law and Society / Revue Canadienne Droit et Société, 1993